BEONE MEDICINES LTD. Shareholders' Equity
BEONE MEDICINES LTD. (BEIGF) had Shareholders' Equity of $5.17 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $5.17B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $4.76B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $4.36B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $4.13B.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $5.17B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $4.76B 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $4.36B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $4.13B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $3.77B 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $3.50B 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $3.33B 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $3.44B 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $3.37B 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $3.36B 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $3.54B 10-K · filed 2026-02-26 | |
| 2023-09-30 | $3.76B 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $3.80B 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $4.16B 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $4.38B 10-K · filed 2026-02-26 | |
| 2022-09-30 | $4.66B 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $5.20B 10-Q · filed 2023-11-09 | $5.30B 10-Q · filed 2022-08-08 |
| 2022-03-31 | $5.77B 10-Q · filed 2023-11-09 | $5.89B 10-Q · filed 2022-05-09 |
| 2021-12-31 | $6.13B 10-K · filed 2025-02-27 | $6.24B 10-K · filed 2022-02-28 |
| 2021-09-30 | $3.36B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.61B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $4.00B 10-Q · filed 2022-05-09 | |
| 2020-12-31 | $3.87B 10-Q · filed 2022-05-09 | |
| 2020-09-30 | $4.29B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.54B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.81B 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $962.21M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.28B 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.55B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.61B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.74B 10-K · filed 2020-03-02 | |
| 2018-09-30 | $1.97B 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.21B 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.34B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $669.81M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $750.14M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $255.75M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $308.42M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $352.91M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $187.83M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $220.05M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $243.10M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$101.77M 10-K · filed 2017-03-22 | |
| 2014-12-31 | -$53.04M 10-K · filed 2017-03-22 |